Literature DB >> 3497797

Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1.

J A Lorenzo, S L Sousa, C Alander, L G Raisz, C A Dinarello.   

Abstract

We compared the bone-resorbing activity in the conditioned medium from phytohemagglutinin (PHA)-stimulated human peripheral blood mononuclear cell cultures with that of partially purified human monocyte-derived interleukin 1 (IL-1), human recombinant IL-1 alpha (pI 5) and IL-1 beta (pI 7), human recombinant tumor necrosis factor-alpha (TNF alpha), and PTH in fetal rat long bone cultures. An antiserum to the products of activated human mononuclear cells, including IL-1, completely blocked the bone-resorbing activity of all three forms of IL-1 and of unfractionated PHA-stimulated human peripheral blood mononuclear cell supernatants, but did not inhibit resorption stimulated by recombinant human TNF alpha. This antiserum also had no effect on the resorptive response to 3 nM PTH, but did decrease the response to 1 nM PTH slightly. These results imply that IL-1, but not TNF alpha, mediates the bone-resorbing activity found in the supernatants of PHA-stimulated human peripheral blood mononuclear cell cultures. It is not known whether the small inhibitory effect that the antiserum to IL-1 had on the response to 1 nM PTH resulted from a nonspecific action or an effect of PTH on local IL-1 synthesis in bone. Since cytokines are found in the circulation of normal individuals and are produced at local sites of pathology, these results suggest that they can influence both normal and abnormal skeletal metabolism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497797     DOI: 10.1210/endo-121-3-1164

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  Is there a causal role for IL-1 in postmenopausal bone loss?

Authors:  R Pacifici
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

Review 2.  Involvement of alpha(v)beta3 integrins in osteoclast function.

Authors:  Ichiro Nakamura; Le T Duong; Sevgi B Rodan; Gideon A Rodan
Journal:  J Bone Miner Metab       Date:  2007-10-25       Impact factor: 2.626

Review 3.  Historically significant events in the discovery of RANK/RANKL/OPG.

Authors:  T John Martin
Journal:  World J Orthop       Date:  2013-10-18

Review 4.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

5.  Expression of typical osteoclast markers by PBMCs after PEG-induced fusion as a model for studying osteoclast differentiation.

Authors:  Luz M Castillo; Carlos A Guerrero; Orlando Acosta
Journal:  J Mol Histol       Date:  2017-03-25       Impact factor: 2.611

6.  Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

Authors:  R B Kimble; J L Vannice; D C Bloedow; R C Thompson; W Hopfer; V T Kung; C Brownfield; R Pacifici
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells.

Authors:  R Pacifici; A Carano; S A Santoro; L Rifas; J J Jeffrey; J D Malone; R McCracken; L V Avioli
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 8.  Osteoimmunology: cytokines and the skeletal system.

Authors:  Seoung-Hoon Lee; Tae-Soo Kim; Yongwon Choi; Joseph Lorenzo
Journal:  BMB Rep       Date:  2008-07-31       Impact factor: 4.778

9.  Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone loss.

Authors:  R B Kimble; R Kitazawa; J L Vannice; R Pacifici
Journal:  Calcif Tissue Int       Date:  1994-10       Impact factor: 4.333

10.  Ciliary neurotrophic factor is an endogenous pyrogen.

Authors:  L Shapiro; X X Zhang; R G Rupp; S M Wolff; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.